Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

BACKGROUND: We assessed the safety and immunogenicity of the RTS,S/AS01 malaria vaccine in a subset of children identified as HIV-infected during a large phase III randomized controlled trial conducted in seven sub-Saharan African countries. METHODS: Infants 6–12 weeks and children 5–17 months old w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine
Hauptverfasser: Otieno, Lucas, Mendoza, Yolanda Guerra, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Gesase, Samwel, Hamel, Mary J., Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kariuki, Simon, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lievens, Marc, Lusingu, John, Malabeja, Anangisye, Masoud, Nahya Salim, Mtoro, Ali Takadir, Njuguna, Patricia, Ofori-Anyinam, Opokua, Otieno, Godfrey Allan, Otieno, Walter, Owusu-Agyei, Seth, Schuerman, Lode, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Vandoolaeghe, Pascale, Sacarlal, Jahit, Oneko, Martina
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613311/
https://ncbi.nlm.nih.gov/pubmed/31708182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.10.077
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge